Format

Send to

Choose Destination
See comment in PubMed Commons below
J Lipid Res. 2013 Mar;54(3):776-85. doi: 10.1194/jlr.M033811. Epub 2013 Jan 14.

Fatty acid synthase causes drug resistance by inhibiting TNF-α and ceramide production.

Author information

1
Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, USA.

Abstract

Fatty acid synthase (FASN) is a key enzyme in the synthesis of palmitate, the precursor of major nutritional, energetic, and signaling lipids. FASN expression is upregulated in many human cancers and appears to be important for cancer cell survival. Overexpression of FASN has also been found to associate with poor prognosis and higher risk of recurrence of human cancers. Indeed, elevated FASN expression has been shown to contribute to drug resistance. However, the mechanism of FASN-mediated drug resistance is currently unknown. In this study, we show that FASN overexpression causes resistance to multiple anticancer drugs via inhibiting drug-induced ceramide production, caspase 8 activation, and apoptosis. We also show that FASN overexpression suppresses tumor necrosis factor-α production and nuclear factor-κB activation as well as drug-induced activation of neutral sphingomyelinase. Thus, TNF-α may play an important role in mediating FASN function in drug resistance.

PMID:
23319743
PMCID:
PMC3617951
DOI:
10.1194/jlr.M033811
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center